Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
| ▸ | CES1 | P23141 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.30 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL893375 | 1.00 | ALDH1A1 (0.33) | ALDH1A1HSD17B10HSD11B1CES2CES1 | |
| SCHEMBL20455768 | 1.00 | ALDH1A1 (0.33) | ALDH1A1HSD17B10HSD11B1CES2CES1 | |
| SCHEMBL892736 | 1.00 | ALDH1A1 (0.33) | ALDH1A1HSD17B10HSD11B1CES2CES1 | |
| SCHEMBL29217487 | 0.96 | ALDH1A1 (0.36) | ALDH1A1HSD17B10HSD11B1CES2CES1 | |
| SCHEMBL893232 | 0.96 | ALDH1A1 (0.36) | ALDH1A1HSD17B10HSD11B1CES2CES1 | |
| SCHEMBL65768 | 0.96 | — | — | |
| SCHEMBL6890483 | 0.96 | — | — | |
| SCHEMBL18239998 | 0.92 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL3957944 | 0.92 | ALDH1A1 (0.33) | ALDH1A1HSD17B10HSD11B1CES2CES1 | |
| SCHEMBL9307017 | 0.92 | ALDH1A1 (0.33) | ALDH1A1HSD17B10HSD11B1CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4417180-A2 | THERMO-ACTIVE COMPOSITE DENTAL COMPOSITION | VOCO GmbH (DE) | 2024-08-21 | — | — | EP | claimed |
| EP-3810064-B1 | THERMOACTIVE DENTAL COMPOSITE COMPOSITION | VOCO GMBH (DE) | 2024-05-29 | — | — | EP | claimed |
| US-11944692-B2 | Thermoactive dental composite composition | VOCO GMBH (DE) | 2024-04-02 | — | — | US | claimed |
| EP-3810064-A1 | THERMOACTIVE DENTAL COMPOSITE COMPOSITION | VOCO GmbH (DE) | 2021-04-28 | — | — | EP | claimed |
| WO-2019243339-A1 | THERMOACTIVE DENTAL COMPOSITE COMPOSITION | VOCO GMBH (DE) | 2019-12-26 | — | — | WO | claimed |
| US-20120184652-A1 | CURABLE RESINS AND ARTICLES MADE THEREFROM | DIGITALOPTICS CORPORATION EAST (US) | 2012-07-19 | — | — | US | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| US-6090853-A | Fungicidally active carboxylic acid amides | BASF AKTIENGESELLSCHAFT (DE) | 2000-07-18 | — | — | US | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| EP-0483167-A4 | ZEOLITE SSZ-33 | — | 1993-03-17 | — | — | EP | claimed |
| EP-0483167-A1 | ZEOLITE SSZ-33 | CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) | 1992-05-06 | — | — | EP | claimed |
| WO-1991000843-A1 | ZEOLITE SSZ-33 | CHEVRON RESEARCH COMPANY (US) | 1991-01-24 | — | — | WO | claimed |
| EP-0171847-B1 | LIQUID, CURABLE COATING COMPOSITION BASED ON A HYDROXYL GROUPS-CONTAINING ADDITION POLYMER AS BINDER | AKZO N.V. (NL) | 1988-06-01 | — | — | EP | claimed |
| US-12318459-B2 | Thermoactive dental composite composition | VOCO GMBH (DE) | 2025-06-03 | — | — | US | disclosed |
| CN-116217566-B | Anti-apoptosis protein BCL-2 inhibitor, pharmaceutical composition and application thereof | 杭州和正医药有限公司 | 2025-05-23 | — | — | CN | disclosed |
| WO-1994029247-A1 | SELECTIVE ALKYLATION OF DIAMONDOID COMPOUNDS WITH AN ALPHA-OLEFIN OVER A LEWIS ACID CATALYST | MOBIL OIL CORPORATION (US) | 1994-12-22 | — | — | WO | disclosed |
| US-5345020-A | Aluminum halide or boron halide | MOBIL OIL CORPORATION (US) | 1994-09-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12318459-B2 | Thermoactive dental composite composition | PUF60, POLQ, F10 | ALDH1A1 1414/4885HSD17B10 2755/4885HSD11B1 4389/4885 |
| US-11944692-B2 | Thermoactive dental composite composition | PUF60, POLQ, F10 | ALDH1A1 1414/4885HSD17B10 2755/4885HSD11B1 4389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.